US Patent 7589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
Patent 7589088 was granted and assigned to Bristol-Myers Squibb on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+60 characters)
Article
Patent abstract
Compounds are provided having the formula (I)
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods US Patent 7589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
Infobox
Patent Number
0758908800
Patent Number
758908800
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075890880
Date of Patent
September 15, 2009
0Patent Application Number
113147950
Date Filed
December 21, 2005
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075890880
Date of Patent
September 15, 2009
0Patent Application Number
113147950
Date Filed
December 21, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07589088
Date of patent
September 15, 2009
Patent application number
11314795
Date Filed
December 21, 2005
Patent primary examiner
Find more entities like US Patent 7589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.